Several recurrent hotspot variants in RET have been identified in MEN 2 patients, and there appears to be some genotype-phenotype correlation, allowing for MTC risk stratification and possible early surgical intervention in affected individuals (6). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.